专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US5597708A Cloning of a malarial gene 失效
标题翻译：克隆疟疾基因
公开(公告)号：US5597708A
公开(公告)日：1997-01-28
申请号：US160158
申请日：1993-12-02
申请人： Anthony A. Holder , Michael J. Lockyer , Jasbir S. Sandhu , Valentina Riveros-Moreno , Karel G. Odink
发明人： Anthony A. Holder , Michael J. Lockyer , Jasbir S. Sandhu , Valentina Riveros-Moreno , Karel G. Odink
IPC分类号： C12N15/09 , A61K20060101 , A61K39/00 , A61K39/015 , A61P31/04 , C07H21/04 , C07K20060101 , C07K14/00 , C07K14/245 , C07K14/44 , C07K14/445 , C07K17/00 , C12N20060101 , C12N1/20 , C12N1/21 , C12N15/00 , C12N15/30 , C12N15/70 , C12P20060101 , C12P19/34 , C12P21/00 , C12P21/02 , C12R20060101 , C12R1/19 , C12R1/90 , C12N15/62
CPC分类号： C07K14/445 , A61K39/00
摘要： The present invention relates to the P.195 gene of Plasmodium falciparum and, more specifically, to the cloning of that gene. The invention further relates to a method of producing the P.195 protein using the cloned gene. The invention also relates to a vaccine comprising the P.195 protein and to the use of same in the prophylaxis of malaria.
摘要翻译：本发明涉及恶性疟原虫的P.195基因，更具体地涉及该基因的克隆。本发明还涉及使用克隆的基因产生P.195蛋白的方法。本发明还涉及包含P.195蛋白质的疫苗以及其在预防疟疾中的用途。

2. 发明公开

EP1330553A4 A KIT FOR DETECTING NON-PATHOGENIC OR PATHOGENIC INFLUENZA A SUBTYPE H5 VIRUS 有权
标题翻译： KIT FOR病毒的或非致病病原流感FROM SUBTYP H5的检测
公开(公告)号：EP1330553A4
公开(公告)日：2004-12-08
申请号：EP01983425
申请日：2001-09-27
申请人： HONG KONG DNA CHIPS LTD
发明人： YU ALBERT CHEUNG HOI , SO KA-LUN , KO LUNG-SANG , LAU LOK-TING
IPC分类号： G01N33/53 , C07H21/04 , C12N15/09 , C12Q20060101 , C12Q1/68 , C12Q1/70 , C12R20060101 , C12R1/92 , C12R1/93 , G01N33/569
CPC分类号： C12Q1/701 , Y02P20/582
摘要： Current methods for detecting influenza A subtype H5 virus, for example cell culture, haemagglutination-inhibition, fluorescent antibody and enzyme immunoassay, and reverse transcriptase polymerase chain reaction (RT-PCR) may have the disadvantages of low sensitivity and low specificity. Furthermore, such methods are relatively difficult to use, and may not be suitable for routine detection on a daily basis. The kit for detecting H5 virus of this invention may provide a user-friendly alternative that is relatively more sensitive and specific to H5 virus. The detection kit utilizes two specially designed primers A and B for the replication of H5 virus, and a specific capture probe for immobilizing the amplified viral RNA. An additional primer C is also designed for the detection of pathogenic H5 virus. The detection of H5 virus by the detection kit may be accomplished within one day if desired.

3. 发明申请

US20050196777A1 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins 失效
标题翻译：阿维链霉菌基因指导B2：B1阿凡曼菌素的比例
公开(公告)号：US20050196777A1
公开(公告)日：2005-09-08
申请号：US11011960
申请日：2004-12-14
申请人： Hamish McArthur , Yoshihiro Katoh
发明人： Hamish McArthur , Yoshihiro Katoh
IPC分类号： C12N15/09 , A01N43/90 , C12N20060101 , C12N1/21 , C12N9/88 , C12N15/60 , C12N15/76 , C12P20060101 , C12P17/18 , C12P19/44 , C12P19/62 , C12R20060101 , C12R1/465 , C12Q1/68 , C07H21/04 , C12N9/10 , C12N15/74
CPC分类号： C12N15/76 , C12N9/88 , C12P17/181 , C12P19/62 , C12P19/623
摘要： The present invention relates to polynucleotide molecules comprising nucleotide sequences encoding an aveC gene product, which polynucleotide molecules can be used to alter the ratio or amount of class 2:1 avermectins produced in fermentation cultures of S. avermitilis. The present invention further relates to vectors, host cells, and mutant strains of S. avermitilis in which the aveC gene has been inactivated, or mutated so as to change the ratio or amount of class 2:1 avermectins produced.
摘要翻译：本发明涉及包含编码aveC基因产物的核苷酸序列的多核苷酸分子，所述多核苷酸分子可用于改变阿维链霉菌发酵培养物中产生的2:1级阿凡曼菌素的比例或量。本发明还涉及阿维链霉菌的载体，宿主细胞和突变菌株，其中aveC基因已被灭活，或突变以改变所产生的2:1级除虫菌素的比例或量。

4. 发明授权

US5674490A Antibiotic GE1655 complex and its factors A, B, and C 失效
标题翻译：抗生素GE1655复合物及其因子A，B和C
公开(公告)号：US5674490A
公开(公告)日：1997-10-07
申请号：US456010
申请日：1995-05-31
申请人： Franco Maria Spreafico , Ernesto Riva , Graziella Beretta , Khalid Islam , Maurizio Denaro
发明人： Franco Maria Spreafico , Ernesto Riva , Graziella Beretta , Khalid Islam , Maurizio Denaro
IPC分类号： A01N63/02 , A01N20060101 , A61K20060101 , A61K35/74 , A61P31/04 , C07G20060101 , C07G11/00 , C12N20060101 , C12P20060101 , C12P1/04 , C12P1/06 , C12P17/08 , C12R20060101 , C12P17/12
CPC分类号： C12P17/08 , C12P1/06
摘要： The present invention is directed to a new antibiotic denominated antibiotic GE1655 complex, its factors antibiotic GE1655 factor A, antibiotic GE1655 factor B, and antibiotic GE1655 factor C, the pharmaceutical acceptable salts thereof, the pharmaceutical compositions thereof, and their use as medicaments against bacteria and fungi, particularly for the treatment of fungal infections in animals and human beings.
摘要翻译：本发明涉及一种新的抗生素抗生素GE1655复合物，其因子是抗生素GE1655因子A，抗生素GE1655因子B和抗生素GE1655因子C，其药学上可接受的盐，其药物组合物及其作为抗细菌药物的用途和真菌，特别是用于治疗动物和人类的真菌感染。

5. 发明授权

US4375542A Kijanimicin antibiotics and derivatives thereof 失效
标题翻译：吉他霉素抗生素及其衍生物
公开(公告)号：US4375542A
公开(公告)日：1983-03-01
申请号：US195048
申请日：1980-10-08
申请人： Jay A. Waitz , Mahesh G. Patel , Ann C. Horan
发明人： Jay A. Waitz , Mahesh G. Patel , Ann C. Horan
IPC分类号： C12P19/60 , A61K20060101 , A61K31/335 , A61K31/535 , A61K31/70 , A61K31/7042 , A61K31/7048 , A61P17/00 , A61P29/00 , A61P31/04 , A61P33/02 , A61P35/00 , C07D313/00 , C07G3/00 , C07G11/00 , C07H17/04 , C07H17/08 , C12N20060101 , C12N1/20 , C12P20060101 , C12P1/06 , C12P17/02 , C12P17/08 , C12P19/44 , C12P19/56 , C12P19/62 , C12R20060101 , C12R1/03
CPC分类号： C12R1/03 , C07H17/08 , C12P19/60
摘要： Actinomadura Kijaniata nov. sp produces a novel antibiotic which we have designated kijanimicin. The antibiotic or cationic salts thereof exhibit anti-acne, antitumor, antimalarial, antibacterial and anti-inflammatory activity.
摘要翻译： Actinomadura Kijaniata nov。 sp产生一种我们已经指定了kijanimicin的新型抗生素。其抗生素或阳离子盐表现出抗痤疮，抗肿瘤，抗疟疾，抗菌和抗炎活性。

6. 发明申请

WO01012821A1 STREPTOMYCES AVERMITILIS GENE DIRECTING THE RATIO OF B2:B1 AVERMECTINS 审中-公开
标题翻译： STRERTOMYCES AVERMITILIS 指定B2的比例：B1 AVERMECTINS

公开(公告)号：WO01012821A1

公开(公告)日：2001-02-22

申请号：PCT/IB2000/001017

申请日：2000-07-24

IPC分类号： C12N15/09 , C12N20060101 , C12N1/21 , C12N9/88 , C12N15/60 , C12N15/76 , C12P20060101 , C12P17/18 , C12P19/44 , C12P19/62 , C12R20060101 , C12R1/465

CPC分类号： C12P17/181 , C12N9/88 , C12P19/623

摘要： The present invention relates to polynucleotide molecules comprising nucleotide sequences encoding an aveC gene product, which polynucleotide molecules can be used to alter the ratio or amount of class 2:1 avermectins produced in fermentation cultures of S. avermitilis . The present invention further relates to vectors, host cells, and mutant strains of S. avermitilis in which the aveC gene has been inactivated, or mutated so as to change the ratio or amount of class 2:1 avermectins produced.

摘要翻译：本发明涉及包含编码aveC基因产物的核苷酸序列的多核苷酸分子，所述多核苷酸分子可用于改变在发酵培养物中产生的2:1级除虫菌素的比例或量。阿维链霉菌的。本发明还涉及载体，宿主细胞和S突变株。阿维菌素其中aveC基因已被灭活或突变，以便改变产生的2：1阿凡曼菌素的比例或量。

7. 发明申请

WO02008438A2 METHODS FOR INCREASING THE PRODUCTION OF ETHANOL FROM MICROBIAL FERMENTATION 审中-公开
标题翻译：从微生物发酵中增加乙醇生产的方法
公开(公告)号：WO02008438A2
公开(公告)日：2002-01-31
申请号：PCT/US2001/023149
申请日：2001-07-23
IPC分类号： C12P7/06 , C12P20060101 , C12R20060101 , C12R1/02 , C12R1/145
CPC分类号： C12P7/065 , C12M21/04 , C12M21/12 , C12M29/02 , C12M29/18 , C12M43/02 , Y02E50/17 , Y02E50/343
摘要： A stable continuous method for producing ethanol from the anaerobic bacterial fermentation of a gaseous substrate containing at least one reducing gas involves culturing a fermentation bioreactor anaerobic, acetogenic bacteria in a liquid nutrient medium; supplying the gaseous substrate to the bioreactor; and manipulating the bacteria in the bioreactor by reducing the redox potential, or increasing the NAD(P)H TO NAD(P) ratio, in the fermentation broth after the bacteria achieves a steady state and stable cell concentration in the bioreactor. The free acetic acid concentration in the bioreactor is maintained at less than 5 g/L free acid. This method allows ethanol to be produced in the fermentation broth in the bioreactor at a productivity greater than 10g/L per day. Both ethanol and acetate are produced in a ratio of ethanol to acetate ranging from 1:1 to 20:1.
摘要翻译：从含有至少一种还原气体的气态底物的厌氧细菌发酵生产乙醇的稳定的连续方法包括在液体营养培养基中培养发酵生物反应器厌氧的乙酰酵母菌; 将气态基质供应到生物反应器; 并且在细菌在生物反应器中达到稳定状态和稳定的细胞浓度之后通过降低氧化还原电位或增加发酵液中的NAD（P）H TO NAD（P）比来操纵生物反应器中的细菌。生物反应器中的游离乙酸浓度保持在低于5g / L游离酸。该方法允许在生物反应器的发酵液中每天以大于10g / L的生产率生产乙醇。乙醇和乙酸乙酯均以乙醇与乙酸乙酯的比例为1：1至20：1生产。

8. 发明专利

JP4456649B2 New probiotic Chicks for pet food 有权
标题翻译：空值
公开(公告)号：JP4456649B2
公开(公告)日：2010-04-28
申请号：JP2008316125
申请日：2008-12-11
申请人：ソシエテ・デ・プロデュイ・ネスレ・エス・アー
发明人：カヴァディーニ、クリストフ , シフリン、エデュアルド , ツィンク、ラルフ , デルヴェイト、ティエリーフォン , ベニヤコーブ、ジャリル , ペレス、パブロ , ルソー、ヴィルジニー , レニエロ、ロベルト , ロシャ、フロランス
IPC分类号： C12N1/20 , A23K20060101 , A23K1/00 , A23K1/14 , A23K1/16 , A23K1/18 , A61K20060101 , A61K35/74 , A61P1/00 , A61P17/00 , A61P31/04 , A61P31/12 , A61P37/02 , A61P37/04 , A61P43/00 , C12N20060101 , C12R20060101 , C12R1/01 , C12R1/23
CPC分类号： C12R1/225 , A23K10/18 , A23K50/42 , A23K50/48 , A61K35/744 , A61K35/745 , A61K35/747 , C12R1/23 , C12R1/46 , Y10S426/805
摘要： The present invention relates to novel lactic acid bacterial micro-organisms that have been isolated and selected for their probiotic potential and their use for the preparation of petfood compositions intended to improve the health of pets, and to compositions containing the same.
摘要翻译：本发明涉及由益生菌潜力分离和选择的新型乳酸菌微生物及其用于制备旨在改善宠物健康的宠物食品组合物的用途，以及含有该宠物的组合物。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式